tbuckley/cabot-search huggingface dataset:
Retrospective Comparison of the Roles of Tocilizumab and Siltuximab in the Management of Toxicity in CAR-T Cell Therapy for Relapsed/Refractory B-NHL
Authors: Rui Liu, Fan Yang, Lixia Ma, Yuelu Guo, Zhonghua Fu, Biping Deng, Chen Chen, Xiaoyan Ke, Kai Hu
Journal: Blood (2024)
Brentuximab Vedotin Is Effective in Sever and Diffuse Lymphomatoid Papulosis, Case Reports
Authors: Hawra Shawayli, Yeslem Mohamed Ekeibed, Shehab Mohamed, Sarah Elkourashy, Afaf Albattah, Dina Sameh Soliman, Ruba Yasin Taha
Journal: Blood (2024)
Trial in Progress: Phase 1/2 Study of Cereblon-Modulating Agent Golcadomide (BMS-986369/CC-99282) in Relapsed or Refractory (R/R) T-Cell Lymphomas (TCLs) (GOLSEEK-3)
Authors: Koji Izutsu, Noriko Fukuhara, Makoto Sugaya, Yuichi Baba, Jin Hayakawa, Mitsufumi Nishio, Alev Akyol, Akshay Sudhindra, Kenji Ishitsuka
Journal: Blood (2024)
Zanubrutinib, Lenalidomide, Rituximab, Temozolomide and Methotrexate (RLZT ± MTX) As First-Line Treatment for Newly Diagnosed PCNSL: A Prospective, Open-Label, Multicenter Clinical Trial
Authors: Rong Fu, Jia Song, Hui Liu, Zongjiu Jiao, Da Gao, Kai Ding, Jie Zhuo, Huijuan Jiang, Shan Gao, Yue Ren, Lijuan Li, Yihao Wang
Journal: Blood (2024)
A Retrospective Study of First and Recurrent Venous Thromboembolism in Patients with Acute Lymphoblastic Leukemia Treated on Total XV and Total Xvi Protocols
Authors: Rohith Jesudas, Justin Kirkham, Tomas Bryndziar, Hiroto Inaba, Timothy Jacobs, Sima Jeha, Victoria Okhomina, Guolian Kang, Cheng Cheng, Clifford M. Takemoto, Ching-Hon Pui, Seth E. Karol
Journal: Blood (2024)
Real-World Analysis of Mycosis Fungoides and Sezary Syndrome in a Lower Middle-Income Country: A 25-Year Retrospective Cohort Study
Authors: Danielle Floyd Aristizábal, Oriana Arias, Elizabeth Arrieta, Nhora Silva, Andres Camilo Rincon, Luisa Maria Betancourth, Alejandra Hidalgo, Andrea Lasso, Bryan Valcarcel, Catalina Proaño, Luis Enrique Malpica Castillo
Journal: Blood (2024)
Treatment with Siltuximab for Short Term Complications after Chimeric Antigen Receptor T-Cell Therapy: A Multicenter Retrospective Analysis
Authors: Jose M. Sanchez-Pina, Pablo Silva, Lucía López-Corral, Anabelle Chinea, Ana Africa Martin Lopez, Nuria Martinez-Cibrian, Rafael Hernani, Victor Noriega, Silvia Filaferro, Pascual Balsalobre, Maria Calbacho, Antonio Pérez-Martínez, Pere Barba, Mi Kwon
Journal: Blood (2024)
Inhibitor-Positive Hemophilia a Patients-Derived Humanized Mouse Models Revealed the Connection of PD-1/PD-L1 Interactions to Successful Immune Tolerance Induction (ITI) Therapy
Authors: Li-Fu Chen, Sheng-Chieh Chou, Yen-Ting Chang, I-Shing Yu, Yu-Chun Liao, Chien-Hung Liu, Shih-Fan Wu, Te-Hsien Liu, Kuei-Liang Chen, Cheng-Pu Sun, Ying-Hui Su, Chin-Yu Cheng, Bin-Bin Lin, Cheng-An Hsu, Mi-Hua Tao, Wen-Chien Chou, Shu-Wha Lin
Journal: Blood (2024)
Efficacy and Safety of Anti-CD19 and Anti-BCMA Chimeric Antigen Receptor (CAR) T-Cell Therapies in Patients with Autoimmune Disease and Lymphoma or Myeloma
Authors: Luca Paruzzo, Riemke Bouvier, Guido Ghilardi, Eugenio Fardella, Bria Fulmer, Ivan J Cohen, Elise A. Chong, Jakub Svoboda, Sunita D. Nasta, Daniel J. Landsburg, Vrutti Patel, Li Ziyu, Raymone Pajarillo, Adam Waxman, Adam D. Cohen, Dan T. Vogl, Stefan K. Barta, Patrizia Porazzi, Joseph A. Fraietta, Vijay Bhoj, Alfred L. Garfall, Edward A. Stadtmauer, Stephen J. Schuster, Jordan S. Carter, Sokratis A. Apostolidis, Sandra Susanibar-Adaniya, Marco Ruella
Journal: Blood (2024)
Humanized Anti-CD25 Monoclonal Antibody for Graft-Versus-Host Disease Prophylaxis in Older Patients Receiving Haploidentical Hematopoietic Stem Cell Transplantation
Authors: Xiaoyu Zhang, Weihua Zhai, Qiaoling MA, Sizhou Feng, Yi He, Mingzhe Han, Erlie Jiang
Journal: Blood (2024)
Golseek-1: A Phase 3, Double-Blind, Randomized Study Comparing the Efficacy and Safety of Golcadomide Plus R-CHOP Vs R-CHOP in Patients with Previously Untreated, High-Risk, Large B-Cell Lymphoma
Authors: Marc Hoffmann, Theodoros Vassilakopoulos, Javier Munoz, Jason R. Westin, Maria Bouzani, Wojciech Jurczak, Michał Kwiatek, Alejandro Berkovits, Tai-Chung Huang, Akshay Sudhindra, Arpankumar Patel, Floriane Boucaud, Adrien Petel, Grzegorz S. Nowakowski
Journal: Blood (2024)
A Multicenter, Open-Label, Phase 1 Clinical Trial of AJ1-11095 Administered As Oral Monotherapy in Patients with Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed By a Type I JAK2 Inhibitor (JAK2i)
Authors: John O. Mascarenhas, Uma Borate, Prithviraj Bose, John C. Byrd, Jacqueline S. Garcia, Michael R. Grunwald, Gabriela S. Hobbs, Ronald Hoffman, Andrew T. Kuykendall, Ruben A. Mesa, Stephen Oh, Raajit Rampal, Abdulraheem Yacoub, David P. Steensma
Journal: Blood (2024)
Ponatinib 2-Year Efficacy, Safety and Health-Related Quality of Life in Patients with Philadelphia Chromosome-Positive Leukemia: An Open-Label, Multicenter, Phase 2 Clinical Trial in China
Authors: Lu Yu, Huifang Wang, Xiaoli Liu, Bingcheng Liu, Xielan Zhao, Qun He, Qingshu Zeng, Zimin Sun, Ting Liu, Huanling Zhu, Zhuogang Liu, Xin Du, Jie Jin, Li Meng, Ming Hou, Suning Chen, Linhua Yang, Mingji Xian, Yoshitaka Kotobuki, Shuang Zhang, Qian Jiang
Journal: Blood (2024)
CD38 Expression As an Additional Prognostic Marker in Mantle Cell Lymphoma
Authors: Matteo D'Addona, Luca Pezzullo, Valentina Giudice, Danilo De Novellis, Idalucia Ferrara, Raffaele Fontana, Roberto Guariglia, Serena Luponio, Laura Mettivier, Maria Carmen Martorelli, Andrea Gigantiello, Denise Morini, Michela Rizzo, Maria Teresa Buonanno, Giuseppe Ciancia, Marisa Gorrese, Bianca Serio, Carmine Selleri
Journal: Blood (2024)
Long-Term Impact of Dose Interruptions (DIs) of Bruton Tyrosine Kinase Inhibitors (BTKis) on Change in IgM Levels and Clinical Outcomes in Waldenström Macroglobulinemia (WM)
Authors: Judith Trotman, Katherine Rankin, Ibrahim Tohidi-Esfahani, Alessandra Tedeschi, Constantine S. Tam, Christian Buske, Roger G Owen, Veronique LeBlond, Meletios A. Dimopoulos, Peter Smallwood, Heather Allewelt, Wai Y Chan, Radha Prathikanti, Jingjing Schneider, Remus Vezan, Stephen S. Opat
Journal: Blood (2024)
Exploring the Tumor Microenvironments of Follicular Helper T-Cell Lymphomas of Angioimmunoblastic-Type and Follicular-Type Using the Geomx® Digital Spatial Profiler
Authors: Jeffrey W Craig, Sahil Chaudhary, Patcharin Pramoonjago, Ipsita Pal, Nathan Roberts, Enrica Marchi
Journal: Blood (2024)
Pathway-Specific Dysregulation in Follicular Lymphoma Correlates to Histological Transformation
Authors: Marie Hairing Enemark, Katharina Wolter, Trine Engelbrecht Hybel, Maja Dam Andersen, Emma Frasez Sørensen, Linnea Meier Hindkær, Kristina Lystlund Lauridsen, Charlotte Madsen, Trine Plesner, Stephen Hamilton-Dutoit, Bent Honoré, Maja Ludvigsen
Journal: Blood (2024)
Real-World Outcomes for Patients Treated with Ibrutinib for Relapsed/Refractory Mantle Cell Lymphoma in Denmark
Authors: Trine Trab, Iman Chanchiri, Ahmed Al-Mashhadi, Emma Berggreen Dall, Stine Rasch, Mette Johansen, Simon Husby, Michael Roost Clausen, Thomas Stauffer Larsen, Andriette C Desseau-Arp, Jacob Haaber Christensen, Robert Schou Pedersen, Mikael Frederiksen, Peter de Nully Brown, Tarec Christoffer El-Galaly, Kirsten Gronbaek
Journal: Blood (2024)
GLUT1 Expressing Circulating Normal and Malignant Plasma Cells Predict Multiple Myeloma Progression
Authors: Paula Tabares, Vincent Petit, Nupur Bhatnagar, Antonio Giovanni Solimando, Jayabhuvaneshwari Dhanraj, Alexis Gonzalez-Diaz, Sanisha Sunuwar, Katharina Schmiedgen, Celia Cartagena, Hüsniye Dagdeviren, Vanessa Desantis, Robin Scheler-Eckstein, Martin K. Kortüm, Leo Rasche, Johannes Waldschmidt, Christian Pinset, Caroline Rougé Dubroc, Hermann Einsele, Andreas Beilhack
Journal: Blood (2024)
<i>TP53</i>-Mutated Therapy-Related Myeloid Neoplasms Are Associated with a Long Latency and Are More Prevalent in Patients with Primary Hematological Cancers Compared to Solid Tumors
Authors: Kevin Hung, Aref Al-Kali, Carla Toop, Mrinal M. Patnaik, Zoe Price, Taxiarchis Kourelis, Daniel Thomas, Morie A. Gertz, Hossein Anani, Wilson I. Gonsalves, Chung Hoow Kok, Ayalew Tefferi, Devendra Hiwase, Mithun V Shah
Journal: Blood (2024)
Treatment Trends and Outcomes of Allogeneic Haematopoeitic Cell Transplantation (HCT) in Acute Lymphoblastic Leukaemia (ALL) in Resource Restricted Setting; A Pakistan Blood and Marrow Transplant Group (PBMT) Study
Authors: Syed Waqas Imam Bokhari, Mehreen Ali Khan, Danyal Ghani, Natasha Ali, Aisha Jamal, Muhammad Saad, Uzma Zaidi, Usman Ahmad, Bushra Ahsan, Sana Khurram, Farrukh Ali Khan, Syed Nasir Abbas Bukhari, Muhammad Nadeem, Lavita Kumari, Tariq Ghafoor, Muhammad Ayaz Mir, Munira Shabbir-Moosajee, Raheel Iftikhar, Tariq Mahmood Satti
Journal: Blood (2024)
Efficacy of Luspatercept on Transfusion Burden and Cytopenias in Intermediate, High, and Very High Risk Myelodysplastic Syndromes
Authors: Daniel Leonard, David Sallman, Kelly Pugh, Christopher S. Bell, Najla H. Al Ali, Uma Borate, Rami S. Komrokji, Andrew M. Brunner
Journal: Blood (2024)
Factors Associated with Acute and Chronic Graft-Versus-Host Disease after Matched Unrelated Donor Hematopoietic Cell Transplantation Using Posttransplant Cyclophosphamide-Based GvHD Prophylaxis
Authors: Moazzam Shahzad, Aqeeb Ur Rehman, Muhammad Kashif Amin, Aleenah Mohsin, Sibgha Gull Chaudhary, Iqra Anwar, Jawad Noor, Rajat Bansal, Matthew McGuirk, Anurag K. Singh, Mehdi Hamadani, Joseph P. McGuirk, Muhammad Umair Mushtaq
Journal: Blood (2024)
Genetic Alterations in Primary and Secondary Plasma Cell Leukemia: A Comparative Study Involving Patients with Non-PCL Myeloma
Authors: Yoko Nakanishi, Tomotaka Suzuki, Takashi Kanamori, Hirokazu Sasaki, Arisa Asano, Shiori Kinoshita, Tomoko Narita, Takaomi Sanda, Masaki Ri, Hirokazu Komatsu, Shinsuke Iida
Journal: Blood (2024)
Results from the Hemophilia Α Cohort of the Non-Investigational Lead-in Study: Prospective Collection of Bleeding Rate in Participants with Hemophilia Α Prior to Phase 3 Study (AFFINE) of Giroctocogene Fitelparvovec
Authors: Laurent Frenzel, Kaan Kavakli, Andrew D. Leavitt, Ali Bülent Antmen, Davide Matino, Margareth Ozelo, Hazza Alzahrani, Barbara A. Konkle, Maria de los Angeles Resa, Annie F. Fang, Jasmine Healy, Delphine Agathon, Francesca Biondo, Frank Plonski
Journal: Blood (2024)
Impact of Absolute Lymphocyte Count on Efficacy and Toxicity of T-Cell Engagers in Non-Hodgkin's Lymphoma
Authors: Jordan Snyder, Nausheen Ahmed, Aqeeb Ur Rehman, Muhammad Umair Mushtaq, Aung M. Tun, Al-Ola Abdallah, Marc Hoffmann, Forat Lutfi
Journal: Blood (2024)
Baseline Characteristics from CLL-ZANU2024, an Italian Non-Interventional Study Assessing the Real-World Use of Zanubrutinib in the Treatment of Patients with Chronic Lymphocytic Leukemia (CLL)
Authors: Enrica Antonia Martino, Raffaella Pasquale, Isacco Ferrarini, Riccardo Moia, Andrea Visentin, Alessandro Sanna, Marina Motta, Massimo Moratti, Paolo Sportoletti, Annalisa Chiarenza, Alessandro Maggi, Valentina Zammit, Michele Merli, Idanna Innocenti, Claudia Giordano, Laura Nocilli, Massimiliano Postorino, Caterina Stelitano, Andrea Ferrario, Annamaria Frustaci, Stefania Scardino, Paola Anticoli Borza, Laura Ballotta, Salvatrice Mancuso, Gerardo Musuraca, Anna Mele, Sara Galimberti, Gioacchino Catania, Annamaria Giordano, Ilaria Angeletti, Luana Schiattone, Elsa Pennese, Rosanna Miccolis, Angelo Fama, Giulio Giordano, Catello Califano, Ernesto Vigna, Antonella Bruzzese, Giuliana Farina, Pietro Bulian, Giacomo Loseto, Barbara Pocali, Vanessa Innao, Piero Galieni, Vincenzo Ludovico Fraticelli, Candida Vitale, Azzurra Anna Romeo, Marco Rossi, Ilaria Scortechini, Federico Vozzella, Luigi Malandruccolo, Enrico Derenzini, Valentina di Martina, Roberto Marasca, Maria Ilaria Del Principe, Marta Coscia, Nicola Di Renzo, Luca Laurenti, Antonino Neri, Pellegrino Musto, Francesco Di Raimondo, Alessandra Tedeschi, Livio Trentin, Gianluca Gaidano, Fortunato Morabito, Valter Gattei, Massimo Gentile
Journal: Blood (2024)
Ptcy Versus High Dose of ATG in HLA-Mismatched Unrelated Stem Cell Transplantation for Hematological Malignancies
Authors: Jonathan Bordat, Eléonore Kaphan, Marie Robin, Flore Sicre de Fontbrune, Florian Chevillon, Gerard Socie, Alienor Xhaard, Regis Peffault de Latour, David Michonneau
Journal: Blood (2024)
Treatment with First-Line Ibrutinib Improves Overall Survival in Patients with Chronic Lymphocytic Leukemia (CLL) and High-Risk Genomic Features to Rates Approximating an Age-Matched US Population: Pooled Analysis of Phase 3 Trials with 10 Years of Follow-up
Authors: Jan A. Burger, Neil E. Kay, John N. Allan, Paul M Barr, Jacqueline C. Barrientos, Carolyn Owen, Victoria Wang, Hsin-Hui Huang, Lynne Neumayr, Christopher Abbazio, Gabriel S. Krigsfeld, Sneh Mody, Paolo Ghia, Tait D. Shanafelt
Journal: Blood (2024)
The Combination of the Novel Trifunctional BCMA NK Cell Engager SAR445514 with IMiDs and Celmods Enhances Cytotoxicity Against Multiple Myeloma Cells As Compared to Single Agents
Authors: Alexandre Tang, Elisa Zaghi, Elodie Perlat, Virginie Boisrobert-D'heilly, Helgi Van de Velde, Alexandre Desjonqueres, Valeria Fantin, Marielle Chiron, Angela Virone-Oddos
Journal: Blood (2024)
Sociodemographic and Patient-Related Determinants of Outcomes after Allogeneic Hematopoietic Cell Transplantation in Acute Leukemia and Myelodysplastic Syndromes
Authors: Muhammad Umair Mushtaq, Aleenah Mohsin, Sibgha Gull Chaudhary, Muhammad Kashif Amin, Iqra Anwar, Matthew McGuirk, Syed Nasir Abbas Bukhari, Kayla Pfannenstiell, Anurag K. Singh, Mehdi Hamadani, Joseph P. McGuirk, Moazzam Shahzad
Journal: Blood (2024)
Apex Part 2 Trial in Progress: A Phase 2 Open-Label Clinical Study of Bezuclastinib in Adult Patients with Advanced Systemic Mastocytosis
Authors: Isaac Goncalves, Stephen Fuller, Jason Gotlib, Pankit Vachhani, Vinod Pullarkat, Daniel J. DeAngelo, Saskia K. Klein, Wolfgang R. Sperr, Karin Hartmann, Khalid Shoumariyeh, Jens Panse, Teng Fong Ng, Miguel Piris-Villaespesa, Tsewang Tashi, Anthony M. Hunter, Prithviraj Bose, Cecilia Y. Arana Yi, Manish Jain, Helena Pomares, Tracy I. George, Jay Patel, Cristina Papayannidis, Minakshi S. Taparia, Bulai Livideanu Cridtina, Juliana Schwaab, Ingunn Dybedal, Jonathan Lambert, Tania Jain, Ewa Wierzbicka-Hainaut, Olivier Hermine, Massimiliano Bonifacio, Gabriela S. Hobbs, Michael W. Deininger, Amanda Pilla, Marcus Carden, Deepti H. Radia
Journal: Blood (2024)
Exercise Prehabilitation for Older Adults Undergoing CAR-T: Feasibility and Preliminary Outcomes from a Single-Arm Pilot Study
Authors: Nathan Parker, Morgan Bean, Mart Theodore De Vera, Rachel Carmella, Jessica McCoy, Salvatore Corallo, Luis Cuadrado Delgado, Meghan Menges, Omar Castaneda, Julio C. Chavez, Rawan Faramand, Michael D. Jain, Heather S.L. Jim, Aleksandr Lazaryan, Sayeef Mirza, Laura B. Oswald, Bijal D Shah, Frederick L. Locke, Ciara Louise Freeman
Journal: Blood (2024)
Haploidentical Transplant Using Selective <i>Ex-vivo</i> TCR-Αβ Depleted and Upfront Memory T-Cell Add-Back Is Associated with Lower Chronic Gvhd and More Favorable Gvhd-Free/Relapse-Free Survival As Compared to Matched Related and Unrelated Donor Transplant for Adults with Hematological Malignancies
Authors: Victor Ling Wei Teik, Yeh Ching Linn, Huirong Han, Michelle Poon, Lip Kun Tan, Joanne Shu Xian Lee, Yang Liang Boo, Ian Wu, Jean Rachel Catapia, Aloysius Yew Leng Ho, William Ying Khee Hwang, Yeow Tee Goh, Francesca Lim, Hein Than, Lawrence Cheng Kiat Ng, Jeffrey Kim Siang Quek, Tertius Tansloan Tuy, Balamurugan Vellayappan, Zi Yi Lim, Colin Phipps Diong, Yvonne Loh, Kheng Wei Yeoh, Brian Ho, Wen Shen Looi, Yin Jie Koh, Teck Guan Soh, Kee Khiang Heng, Gina Gan, Wing Leung, Liang Piu Koh
Journal: Blood (2024)
Feasibility of Co-Administration of Autologous NK Cells and Anti-CD38 Monoclonal Antibody Isatuximab, in Multiple Myeloma Post-Autologous HSCT in a Randomized Phase 2 Clinical Trial
Authors: Johan Lund, Stephan Meinke, Muhammad Kashif, Anna Bohlin, Eva Hellstrom Lindberg, Hans-Gustaf Ljunggren, Evren Alici
Journal: Blood (2024)
Optimizing Molecular Diagnosis of Systemic Mastocytosis in the Era of KIT Tyrosine Kinase Inhibitors: Results of a Survey and of a Nationwide Proficiency Control Round of KIT D816V Mutation Testing Promoted By the RIMA (Rete Italiana MAstocitosi) Association
Authors: Simona Soverini, Cecilia Monaldi, Sara De Santis, Manuela Mancini, Francesco Albano, Luisa Anelli, Loredana Bruno, Ignazio Brusca, Grazia Fazio, Lilia Maria Corral Abascal, Francesca Guerrini, Clara Bono, Giovanni Iaquinta, Paola Grammatico, Elisabetta Novella, Omar Perbellini, Orietta Spinelli, Silvia Salmoiraghi, Stefano Baldoni, Alessia Persico, Giuseppa De Luca, Calogero Lauricella, Giovanna Piras, Angelo D. Palmas, Samantha Bruno, Cristina Mosca, Chiara Sartor, Cristina Papayannidis, Paola Guglielmelli, Alessandro M. Vannucchi, Patrizia Bonadonna, Francesco Mannelli, Nicholas C. P. Cross, Michele Cavo, Roberta Zanotti, Chiara Elena
Journal: Blood (2024)
Mutational and Clinical Characteristics Associated with Atherosclerotic Disease Burden in the MDS Canada Database: A Single-Center Analysis of CT Coronary Artery Calcium Scores
Authors: Arjun Pandey, Idan Roifman, Bo Wan, Tara Williams, James Kennedy, Signy Chow, Lee Mozessohn, Lisa Chodirker, Alexandre Mamedov, Iran Rashedi, Mohammed Siddiqui, Rashmi S. Goswami, Rena Buckstein
Journal: Blood (2024)
Anchored Indirect Treatment Comparison Finds Comparable Effects of Pegcetacoplan and Iptacopan in Paroxysmal Nocturnal Hemoglobinuria
Authors: Régis Peffault de Latour, Jeffrey Szer, Koo Wilson, Piotr Wojciechowski, Zalmai Hakimi, Jameel Nazir, Barbara Czech, Austin G. Kulasekararaj
Journal: Blood (2024)
<i> <i>STAG2</i> </i> Mutations Drive Development of Myelodysplastic Syndromes by Promoting R-Loop-Mediated Genomic Instability and Activation of cGAS-STING
Authors: Lin Han, Benjamin Braun, Caroline A. Conway, Amy Wang, Johann-Christoph Jann, Yihua Wang, Kate I. Drachman, Qingqing Yan, Elodie Hatchi, Phillip Wulfridge, William Doyle, Caroline N. Pitton, Kavitha Sarma, Zuzana Tothova
Journal: Blood (2024)
Prognostic Implication of Framingham Risk Score As a Comorbidity Measure on Treatment Outcomes Following First-Line Tyrosine Kinase Inhibitor in Newly Diagnosed CML Patients
Authors: May Chiu, Maria Agustina Perusini, Jaeyoon John Kim, Danielle Pyne, Muzaffar Bhatti, Anthea Travas, Oyeronke Ayansola, Amirtha Ambalavanan, Jenny Ho, Dennis Dong Hwan Kim
Journal: Blood (2024)
Nationwide Multicenter Real-World Survey of CAR-T Cell Toxicity Prophylactic and Treatment Management Strategies
Authors: Eleni Gavriilaki, Ifigeneia Tzannou, Anna Vardi, Ioannis Tsonis, Maria Liga, Kostantinos Gkirkas, Maria Ximeri, Zoi Bousiou, Maria Bouzani, Eleftheria Sagiadinou, Panagiotis Dolgyras, Nikolaos Kotsiou, Vasiliki Bampali, Despina Mallouri, Tatiana Tzenou, Ioannis Batsis, Damianos Sotiropoulos, Stavros Gigantes, Helen A Papadaki, Panagiotis Tsirigotis, Alexandros Spyridonidis, Theodoros P. Vassilakopoulos, Maria Angelopoulou, Ioannis Baltadakis, Ioanna Sakellari
Journal: Blood (2024)
Modified Psychosocial Assessment of Candidates for Transplantation Predicts Clinical Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation
Authors: Hiroyuki Kubo, Osamu Imataki, Tetsuya Fukumoto, Tomoya Ishida, Yukiko Hamasaki Kubo, Maki Oku, Yui Kawanaka, Yu Suezawa, Shunsuke Yoshida, Shumpei Uchida, Makiko Uemura, Haruyuki Fujita, Norimitsu Kadowaki
Journal: Blood (2024)
The Effect of Oral Iptacopan Monotherapy on Hematological Parameters in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Is Consistent Regardless of the Type of Prior Anti-C5 Treatment Received: A <i>Post Hoc</i> Analysis of 24-Week Data from the Randomized Phase III APPLY-PNH Trial
Authors: Regis Peffault De Latour, Austin G. Kulasekararaj, Phillip Scheinberg, Yasutaka Ueda, Carlos de Castro, Samopriyo Maitra, Philippe Ferber, Marion Dahlke, Antonio M Risitano
Journal: Blood (2024)
Excellent Clinical Outcomes in Deeply Mutated IGHV Chronic Lymphocytic Leukemia upon Fludarabine and Cyclophosphamide Plus Rituximab
Authors: Andreas Katsimigas, Lone Bredo Pedersen, Thure Haunstrup, Thor Hoeyer, Rikke Olsen, Michael Boe Møller, Emelie Curovic Rotbain, Caspar Da Cunha-Bang, Carsten Utoft Niemann, Christian Brieghel
Journal: Blood (2024)
Mogamulizumab Shows Significant Activity with Tolerable Toxicity in a Real-World North American Adult T-Cell Leukemia/Lymphoma (ATLL) Cohort
Authors: Emma Cordover, Kith Pradhan, Latoya S. Townsend, Mendel Goldfinger, Ioannis Mantzaris, Nishi Shah, Aditi Shastri, Noah Kornblum, Dennis L Cooper, Ridhi Gupta, Lauren Shapiro, Kira Gritsman, Marina Konopleva, Alyssa de Castro, Roy Browne, Salvatore Lia, Amit Verma, Ali Bazarbachi, B. Hilda Ye, Murali Janakiram, R. Alejandro Sica
Journal: Blood (2024)
Correlation between Peak Absolute Lymphocyte Count Post Brexucabtagene Autoleucel Infusion and Outcomes in Mantle Cell Lymphoma
Authors: Suheil Albert Atallah-Yunes, Matthew James Rees, Javier Munoz, Jonas Paludo, Muhamad Alhaj Moustafa, Arushi Khurana, Jose C. Villasboas Bisneto, Allison C. Rosenthal, Januario E. Castro, Madiha Iqbal, Mohamed A. Kharfan-Dabaja, N. Nora Bennani, Paul J. Hampel, Urshila Durani, Patrick B. Johnston, Andre De Menezes Silva Corraes, Luis Porrata, Stephen M. Ansell, Yi Lin, Yucai Wang
Journal: Blood (2024)
Characterization of Skin Response in Patients with Mycosis Fungoides and Sezary Syndrome Treated with Mogamulizumab: A Retrospective, Real World Cohort
Authors: Rachel Christensen, Robert Stuver, Stephen Dusza, Zachary D. Epstein-Peterson, Paola Ghione, Steven Horwitz, William T. Johnson, Alison Moskowitz, Patricia Myskowski, Melissa Pulitzer, Shamir Geller
Journal: Blood (2024)
Outcomes of Rituximab and Bendamustine Induction Regimen VS Cytarabine-Based Induction for Patients with Mantle Cell Lymphoma
Authors: Yanal Alnimer, Fevzi Yalniz, Gregory Monohan, Reinhold Munker, Ayman Qasrawi, Chait Iragavarapu, Mahmoud Amr
Journal: Blood (2024)
Venetoclax in Combination with Hypomethylating Agent (HMA) Compared to HMA Alone Improves Response but Not Survival in <i>TP53-</i>mutated High-Risk Myelodysplastic Syndrome: Real-World Mayo Clinic Series
Authors: Talha Badar, Kashish J. Shah, Mobachir El Kettani, James M. Foran, Mohamed A. Kharfan-Dabaja, Hemant S. Murthy, Naseema Gangat, Aref Al-Kali, Mithun V Shah, Hassan B Alkhateeb, Antoine N. Saliba, William J. Hogan, Cecilia Y. Arana Yi, Lisa Sproat, Jeanne Palmer, Mark R. Litzow, Mrinal M. Patnaik
Journal: Blood (2024)
Sorafenib Combined with Chemotherapy and Donor Lymphocyte Infusion for Patients with FLT3 Wild-Type Acute Leukemia Relapsing after Allo-HSCT
Authors: Tian Zhang, Peiru Chi, Zhiping Fan, Na Xu, Hui Xu, Fen Huang, Ren Lin, Zhixiang Wang, Hui Liu, Xueying Ou, Ke Zhao, Ling Jiang, Jing Sun, Qifa Liu, Li Xuan
Journal: Blood (2024)
Prophylaxis with Thiotepa and High-Dose Methotrexate Showed Low CNS Relapse Rate in Diffuse Large B-Cell Lymphoma with High Risk of CNS Relapse
Authors: Ruolan Zeng, Zhou Ouyang, Yajun Li, Yizi He, Caiqin Wang, Chen Xia, Zhongtai Wang, Yixue Li, Yinhua Liu, Weiqiang Tang, Qianying Ouyang, Liang Liang, Chang Su, Guige Lu, Xueting Zhu, Qianyu Hu, Ling Xiao, Hui Zhou
Journal: Blood (2024)
Strikingly Reduced Toxicities of Fotemustine-Based Chemotherapeutics Than High-Dose Methotrexate-Containing Regimens with Comparable Efficacy
Authors: Xudong Zhang, Mengke Fan, Wenhua Wang, Jingjing Wu, Shanshan Ma, Meng Dong, Linan Zhu, Xiaolong Wu, Xiaoyan Feng, Xin Li, Ling Li, Zhenchang Sun, Xinhua Wang, Xiaorui Fu, Zhaoming Li, Jiaqin Yan, Yu Chang, Hui Yu, Feifei Nan, Zhiyuan Zhou, Mengjie Ding, Jieming Zhang, Lei Zhang, Mingzhi Zhang
Journal: Blood (2024)
Use of Doxorubicin-Containing Regimens Is Not Associated with Hemolytic Complications in Severely G6PD Deficient Patients with Lymphoma
Authors: Shruti Prem Sudha, Fatima Al-ali, Atef Shehata, Nabil Abdelfattah, Taif Najeebi, Cigdem Ozturk, Aly Sobhy Rashed, Manu Venkatesan, Rehab Helmy
Journal: Blood (2024)
The Mutational Profile and Fusion Landscape of Chinese Pediatric B-Cell Lymphoblastic Lymphoma Patients
Authors: Yang Li, Ling Jin, Ying Liu, Yueping Jia, Yunpeng Dai, Lihua Yang, Rong Liu, Lian Jiang, Zhongjin Xu, Ansheng Liu, Xiaojun Yuan, Jian Wang, Qinlong Zheng, Yonghong Zhang
Journal: Blood (2024)